Drug research firm Huntingdon Life Sciences has been saved from closure after holding talks late into the night in a bid to secure its financial future.
It is understood that the Royal Bank of Scotland was to end its links with the Cambridgeshire firm and would be replaced by a US financial group.
The Royal Bank of Scotland had been deciding whether to extend a crucial £22.6 million sterling loan facility.
In a statement issued to the Stock Exchange, HLS said it was continuing discussions with "interested parties with a view to refinancing its bank facility".
HLS's financial problems stemmed from being targeted by animal activists, who have put pressure on shareholders to sell their investments in the group in an attempt to put it out of business.
PA
